| 期刊全称 | Acute Myeloid Leukemia | | 影响因子2023 | Christoph Röllig,Gert J. Ossenkoppele | | 视频video | | | 发行地址 | Explanation of diagnostic workup and disease classification.Clear guidance on initial treatment and relapse strategies.Information on optimal use of newly approved agents | | 学科分类 | Hematologic Malignancies | | 图书封面 |  | | 影响因子 | This book, written by a team of leading experts, provides a comprehensive overview of acute myeloid leukemia (AML), the most frequent acute leukemia in adults. The opening chapters present current knowledge of epidemiology, etiologic factors, and the pathogenesis and molecular development of AML. Detailed guidance is offered on laboratory and clinical diagnostic workup and disease classification, and the patient- and disease-related factors that determine prognosis and treatment allocation are identified. On the basis of these general considerations, initial treatments in patients considered fit for intensive treatment and in older and co-morbid patients are reviewed, and the available relapse treatment strategies, explained. For all clinical scenarios, the most recent data on the optimal use of newly approved agents in different AML subgroups are presented. Separate chapters address the treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for in | | Pindex | Book 2021 |
The information of publication is updating
|
|
发表于 2025-3-21 17:21:34
